Phase 3 COPD Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are between 40 and 80 years old (inclusive) at the time of signing the consent form.
- You have a higher-than-normal level of a type of white blood cell called eosinophils in your blood.
- You have been diagnosed with moderate to severe COPD (chronic obstructive pulmonary disease) for at least 1 year, confirmed by a breathing test showing specific results.
- You have had at least 2 moderate flare-ups (exacerbations) or at least 1 severe flare-up of your COPD in the past 12 months.
- You scored 10 or higher on a standard COPD symptom questionnaire called the CAT (COPD Assessment Test).
- You are a current or former cigarette smoker with at least 10 pack-years of smoking history (for example, 1 pack per day for 10 years, or 2 packs per day for 5 years).
- You have been using a combination of three inhaled medications (an inhaled steroid, plus two different types of long-acting inhalers) for at least 6 months before the screening visit.
- Your body mass index (a measure of body weight relative to height) is at least 16.
- You are male, or a female who meets the trial's specific eligibility requirements (confirm with trial site).
Who may not be able to join:
- You have been diagnosed with asthma by a doctor, either now or in the past.
- You have another significant lung condition where COPD is not considered your main lung problem.
- You have had pneumonia, a COPD flare-up, or a lower respiratory tract infection in the 4 weeks before your screening visit.
- You have had lung volume reduction surgery or a procedure involving endobronchial valves, or you are planning to have one.
- You have been in an active pulmonary rehabilitation (lung exercise) program within the 4 weeks before your screening visit.
- You need to use supplemental oxygen for more than 12 hours per day.
- You have a serious heart condition related to lung problems, such as right heart failure or severe high blood pressure in the lungs.
- You need to use a breathing support machine at night or during the day (such as BiPAP or CPAP) due to a build-up of carbon dioxide in your blood.
- You have an unstable heart condition or an irregular heartbeat.
- You have had a known parasitic infection within the 6 months before your screening visit.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: GSK Clinical Trials, GlaxoSmithKline
Phone: 877-379-3718
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Annualized Rate of Moderate/Severe Exacerbations
Can't join this trial?
Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.